Activity of Bosutinib, Dasatinib, and Nilotinib Against 18 Imatinib-Resistant BCR/ABL Mutants

Sara Redaelli(University of Milano-Bicocca), Rocco Piazza(University of Milano-Bicocca), Roberta Rostagno(University of Milano-Bicocca), Vera Magistroni(University of Milano-Bicocca), Pietro Perini(University of Milano-Bicocca), Manuela Marega(University of Milano-Bicocca), Carlo Gambacorti‐Passerini(University of Milano-Bicocca), Frank Boschelli(Synergy Pharmaceuticals (United States))
Journal of Clinical Oncology
December 16, 2008
Cited by 397Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis